Clinical Scorecard: Metabolomics: An Emerging Approach for Addressing Prevention, Diagnosis, and Management of Obesity

At a Glance

Key Highlights

• Plasma and fecal metabolites show positive and negative associations with BMI, BMI Z score, and body fat indicators in children.
• Metabolomics may enable early identification of children at risk for obesity before clinical signs appear.
• Metabolite profiles could serve as therapeutic targets and monitoring tools for dietary and medical interventions in pediatric obesity.

Guideline-Based Recommendations

Diagnosis

• Consider metabolomic profiling to identify metabolic signatures associated with obesity risk before clinical adiposity develops.

Management

• Incorporate dietary interventions that influence beneficial metabolites (e.g., diets rich in whole grains, nuts, fruits, vegetables, fish).
• Explore metabolite-targeted therapies such as antiobesity medications guided by metabolomic changes.

Monitoring & Follow-up

• Use changes in plasma and fecal metabolites as biomarkers to assess adherence and response to lifestyle or pharmacologic treatments.

Risks

• Recognize limitations of cross-sectional metabolomic studies and lack of established causality.
• Avoid unethical interventions such as randomized high-fat diets in children.

Patient & Prescribing Data

Children with obesity or at risk of obesity aged 6 to 9 years

Antiobesity medications show more significant changes in BMI percentile than lifestyle alone, but metabolomic changes with these treatments remain unstudied.

Clinical Best Practices

• Control for confounders such as pubertal status when assessing metabolomic data in pediatric populations.
• Use metabolomics alongside traditional anthropometric measures to improve early detection and personalized management of obesity.
• Promote dietary patterns similar to the New Nordic or Mediterranean diets to favor protective metabolite profiles.
• Recognize the potential of metabolomics to guide preventive strategies before obesity onset and to monitor treatment efficacy.

References

• Hong et al study on plasma and fecal metabolites and obesity
• Study on elevated fumaric acid levels with New Nordic Diet
• Study on metabolite changes in mice fed high-fat diet
• Previous study on gut microbiome and short-chain fatty acids association with obesity